Reoperation does not provide a survival advantage in patients with recurrent Glioblastoma treated with irinotecan/bevacizumab treatment

Conclusion: The second surgery in recurrent GBM has limited effect in clinical course.
Source: Indian Journal of Cancer - Category: Cancer & Oncology Authors: Source Type: research